$105.50+28.38% · 3M
Moving avg
1W+1.04%
1M+10.29%
3M+28.38%
6M+37.16%
YTD+15.84%
1Y+13.47%
3Y+50.50%
5Y+52.30%
52-week range
$72.7699% of range$105.96
Company health
Value0/6
Growth6/6
Profitability5/6
Health5/6
Dividend0/6
Bull vs bear
Strengths
- Analyst consensus is "Buy"
- High return on equity (1094%)
- Revenue compounding 28% a year
Risks
No obvious red flags from the metrics.
Key statistics
Valuation
Market cap
$8.82B
Enterprise value
$8.99B
P/E ratio (TTM)
36.62x
P/S ratio (TTM)
6.18x
EV/EBITDA
19.60x
Per share & returns
EPS (TTM)
$2.73
Dividend yield
0.00%
Beta (1Y)
0.21
30-day change
+10.29%
Trading
Volume (24h)
525.58K
Previous close
$105.57
Shares outstanding
83.60M
About HealthEquity, Inc.
Sector
Healthcare
Industry
Medical - Healthcare Information Services
Exchange
NASDAQ
Symbol
HQY
HealthEquity, Inc. is a mid-cap healthcare company in the Medical - Healthcare Information Services industry. Its shares are listed on NASDAQ (United States) and trade under the ticker HQY.
Frequently asked questions
What is HealthEquity, Inc.'s market cap?
HealthEquity, Inc. (HQY) has a market capitalization of $8.82B.
What is HealthEquity, Inc.'s P/E ratio?
HealthEquity, Inc. trades at a price-to-earnings (P/E) ratio of 36.62.
What exchange does HQY trade on?
HQY trades on NASDAQ.
Appears in
Eli Lilly and CompanyLLY
$1,220.51+0.45%
$1.15T cap
Johnson & JohnsonJNJ
$260.86+0.41%
$628.65B cap
AbbVie Inc.ABBV
$248.66-0.57%
$439.33B cap
UnitedHealth Group IncorporatedUNH
$405.59+0.85%
$368.33B cap
Roche Holding AGSWX: ROP
CHF 365.50-0.92%
$357.56B cap
Merck & Co., Inc.MRK
$132.93+1.92%
$328.31B cap
Novartis AGSWX: NOVN
CHF 124.20-1.32%
$290.12B cap
AstraZeneca PLCLON: AZN
£117.02-1.20%
$244.93B cap